Bruce Feinberg, DO, Speaks About Clinical Pathways in Oncology Care
Bruce Feinberg, DO, Vice President and Chief Medical Officer, Cardinal Health Specialty Solutions, says that there is a tremendous amount of waste in the system. "Waste in the system is created by ineffective technology and claims processing that is very cumbersome for both payers and providers," says Dr. Feinberg.
This video was taken on November 16 at AJMC's Translating Evidence-Based Research Into Value-Based Decisions in Oncology.
The FDA today granted accelerated approval to olaparib, a poly ADP-ribose polymerase (PARP) inhibitor, for treatment of advanced ovarian cancer in women with defected BRCA genes, along with a companion diagnostic test that marked the agency’s first approval of a laboratory developed test (LDT) under a premarket approval application.
Fresh off re-election, Governor Robert Bentley moved this week to name 6 groups to coordinate managed care in Medicaid, as part of a cost-saving strategy he launched in 2012. But the bigger news has been his reversal on expanding the program; as in other Southern states, hospitals have been pressing for the change to solve fiscal problems.
In this segment, the panelists analyze current programs that aim to educate and guide key stakeholders through the facets of cancer care and conclude that collaboration can help control costs and drive quality.
All medical illnesses have issues with nonadherence and part of the reason is because the American health system doesn’t provide the right education, support, and close follow-up needed to get the right medicine to the right person, Wayne Katon, MD, said.
Wayne Katon, MD, addresses the concern of overdiagnosis in mental health, which results in an overuse of drugs like Prozac for people with minor depression. He attributed the problem to the fact that primary care physicians have difficulty getting people into the therapy they need and have to result to medications.